Open Access ARTICLE Early GLP-1 Agonist Use and Cancer Risk in Type 2 Diabetes: A Real-World Data Cohort Study 1 Institute of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan 2 Department of Emergency Medicine, School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan 3 Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung, 402, Taiwan 4 Department of Internal Medicine, Zuoying Armed Forces General Hospital, Kaohsiung, 813, Taiwan 5 Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan 6 Graduate Institute of Aerospace and Undersea Medicine, College of Biomedical Sciences, National Defense Medical University, Taipei, 114, Taiwan 7 Department of Orthopedic Surgery, Chung Shan Medical University Hospital, Taichung, 402, Taiwan 8 School of Medicine, Chung Shan Medical University, Taichung, 402, Taiwan 9 Department of Medical Research, Chung Shan Medical University Hospital, Taichung, 402, Taiwan * Corresponding Authors: Yu-Hsun Wang
Even with their power, it is clear that medication alone is not enough: When people stop taking the medication, studies show the weight comes back
It arrives in a multi-dose vial
Why would this matter
